Safetreat 1.125gm Injection
Marketer
Human Bio Organics Pvt Ltd
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Safetreat 1.125gm Injection
Combiflox 1.125g Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation, curbing infection spread. Administration must be overseen by a medical professional. Strictly adhere to the prescribed dosage schedule; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are potential side effects; worsening symptoms necessitate immediate medical attention. Seek urgent medical care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased somnolence. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration facilitate recovery. Monitoring may involve laboratory tests to assess treatment response.
Primary Ingredients of Safetreat 1.125gm Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Safetreat 1.125gm Injection
Infections caused by bacteria
Major Benefits of Safetreat 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Safetreat 1.125gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Safetreat 1.125gm Injection:
The medication will be administered by your physician or registered nurse; please do not self-medicate.
How Safetreat 1.125gm Injection works:
The injectable formulation Safetreat 1.125gm combines ceftazidime, a bacterial cell wall synthesis inhibitor, with tazobactam, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall formation, thereby hindering bacterial survival. Tazobactam counters bacterial resistance mechanisms, augmenting ceftazidime's antimicrobial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Safetreat 1.125gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Employing Safetreat 1.125gm Injection during pregnancy is typically deemed safe. Preclinical trials using animals revealed minimal or no harmful consequences for offspring; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Safetreat 1.125gm Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Administering Safetreat 1.125gm Injection may induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Safetreat 1.125gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Safetreat 1.125gm Injection to individuals suffering from advanced hepatic impairment. Dosage modification of Safetreat 1.125gm Injection might be necessary. Physician consultation is recommended.
What if you forget to take Safetreat 1.125gm Injection :
Omit a Safetreat 1.125gm Injection dose? Seek medical advice immediately.
Facts to Know About Safetreat 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently